JPS5616412A - Carcinostatic agent - Google Patents

Carcinostatic agent

Info

Publication number
JPS5616412A
JPS5616412A JP9177979A JP9177979A JPS5616412A JP S5616412 A JPS5616412 A JP S5616412A JP 9177979 A JP9177979 A JP 9177979A JP 9177979 A JP9177979 A JP 9177979A JP S5616412 A JPS5616412 A JP S5616412A
Authority
JP
Japan
Prior art keywords
agent
carcinostatic
salt
benzopyran
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9177979A
Other languages
Japanese (ja)
Inventor
Shinichi Kuwabara
Yoshiaki Ikeda
Keizo Ito
Hisashi Nose
Isamu Uchiumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP9177979A priority Critical patent/JPS5616412A/en
Publication of JPS5616412A publication Critical patent/JPS5616412A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)

Abstract

PURPOSE: A carcinostatic agent with low toxicity, having both direct carcinostatic action and carcinostatic action through a host, comprising a benzopyran-based compound KB-53, or its salt as an active ingredient.
CONSTITUTION: A carcinostatic agent comprising a compound shown by the formula such as KB-53 [chemical name trans-2-(3,4-dihydroxyphenyl)-3,4-dihydro- 2H-1- benzopyran-3,5,7-triol) or its salt as an active ingredient. A salt of alkali metal, alkaline alkali earth metal, B, an aluminum element, or an organic amine is effective as the salt. The agent is administered in the drug form of tablet, capsule, infection, suppository, syrup, and ointment. 250W3,000mg of the agent is dosed daily in one to three times. The agent has a chemical structure that is completely different from that of an existing agent, marking a new field in a carcinostatic agent.
COPYRIGHT: (C)1981,JPO&Japio
JP9177979A 1979-07-18 1979-07-18 Carcinostatic agent Pending JPS5616412A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9177979A JPS5616412A (en) 1979-07-18 1979-07-18 Carcinostatic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9177979A JPS5616412A (en) 1979-07-18 1979-07-18 Carcinostatic agent

Publications (1)

Publication Number Publication Date
JPS5616412A true JPS5616412A (en) 1981-02-17

Family

ID=14036067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9177979A Pending JPS5616412A (en) 1979-07-18 1979-07-18 Carcinostatic agent

Country Status (1)

Country Link
JP (1) JPS5616412A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03176065A (en) * 1981-06-19 1991-07-31 Chem Fab Stockhausen Gmbh Absorbing agent
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
JP2016518422A (en) * 2013-05-17 2016-06-23 バロールＶａｌｏｒｅ Composition comprising (+)-catechin and amino acid complex for the treatment and prevention of cancer

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03176065A (en) * 1981-06-19 1991-07-31 Chem Fab Stockhausen Gmbh Absorbing agent
JPH0471926B2 (en) * 1981-06-19 1992-11-17 Hemitsushu Fuaburitsuku Shutotsukuhauzen Gmbh
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
JP2016518422A (en) * 2013-05-17 2016-06-23 バロールＶａｌｏｒｅ Composition comprising (+)-catechin and amino acid complex for the treatment and prevention of cancer

Similar Documents

Publication Publication Date Title
ES8403024A1 (en) Pharmaceutical preparations.
JPS5616412A (en) Carcinostatic agent
JPS52108028A (en) Remedies for dysacousis
JPS5396388A (en) Preparation of l-phenylalanine
JPS5470428A (en) Carcinostatic agent
JPS5634626A (en) Anti-inflammatory
JPS51128438A (en) An antibacterial drug against fish diseases
JPS5545656A (en) Carcinostatic agent
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS57158719A (en) Rectal administration pharmaceutical
JPS56118015A (en) Immunological activator containing organic germanium compound
JPS5731616A (en) Relaxing agent for muscle comprising benzofurancarboxylic acid amide
JPS5296692A (en) Production of sodium polyacrylate
JPS5634625A (en) Antitumorigenic agent
JPS5489039A (en) Anti-bacterial agent
JPS5325534A (en) Mandelic acid glucosides and their anti-cancerous preparations
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
JPS5562017A (en) Anti-inflammatory agent comprising guanidine derivative
JPS5312417A (en) Preparation of amorphous d rugs
JPS53149910A (en) Preparation of 1,3-dicarbonyl compound derivatives
JPS57136519A (en) Antidiabetic containing aminobenzoic acid derivative
JPS52128302A (en) Preparation of amide compounds
JPS52108951A (en) Epoxy alcohol derivatives and preparation thereof
JPS5545658A (en) Carcinostatic agent